PRIMERICA ALERT: Bragar Eagel & Squire, P.C. is Investigating Primerica Inc. on Behalf of Primerica Stockholders and Encourages Investors to Contact the Firm
29 avr. 2024 06h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Primerica Inc....
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Caribou, Verrica, and Playstudios on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
27 avr. 2024 06h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 27, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors Caribou...
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Talis, TaskUs, and RTR on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
27 avr. 2024 06h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 27, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors Talis Biomedical...
CIDARA Therapeutics ALERT: Bragar Eagel & Squire, P.C. is Investigating Cidara Therapeutics, Inc. on Behalf of Cidara Therapeutics Stockholders and Encourages Investors to Contact the Firm
25 avr. 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Cidara Therapeutics, Inc....
ENDEAVOR ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of EDR and Encourages Investors to Contact the Firm
25 avr. 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or...
REVIVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Reviva Pharmaceuticals Holdings, Inc. on Behalf of Reviva Stockholders and Encourages Investors to Contact the Firm
25 avr. 2024 05h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Reviva Pharmaceuticals...
AGILITI ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of AGTI and Encourages Investors to Contact the Firm
25 avr. 2024 05h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or...
LANTRONIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Lantronix, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
24 avr. 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Lantronix, Inc. (NASDAQ:...
TANDEM ALERT: Bragar Eagel & Squire, P.C. is Investigating Tandem Diabetes Care, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
23 avr. 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Tandem Diabetes Care,...
MOBILEYE ALERT: Bragar Eagel & Squire, P.C. is Investigating Mobileye Global Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
22 avr. 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Mobileye Global Inc....